Artwork
iconShare
 
Manage episode 498290355 series 3681542
Content provided by SleepWorld Magazine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by SleepWorld Magazine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

This podcast is adapted from a news release "Positive Topline Results from Second Phase 3 Trial of First OSA Pill" Apnimed's successful outcomes AD109, an oral drug candidate designed to treat Obstructive Sleep Apnea (OSA). Results from the LunAIRo and SynAIRgy Phase 3 clinical trials demonstrate the drug's effectiveness in reducing airway obstruction and improving oxygenation in patients with mild, moderate, and severe OSA.
You can read the full article here: https://sleepworldmagazine.com/2025/07/23/positive-topline…f-first-osa-pill/
Start a free subscription to SleepWorld Magazine: https://hubs.li/Q03gs4dg0
Check out more sleep-related podcasts here: https://sleepworldpodcastnetwork.com/

  continue reading

6 episodes